Vision shapes behavior, and a new study by MIT neuroscientists finds behavior and internal states shape vision. The research, ...

Novartis secures FDA approval for Itvisma, a one-time gene therapy designed to boost motor function across a broad SMA ...

Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated ...

Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function ...

Researchers at Karolinska Institutet, Columbia University and the University of San Francisco, have uncovered a previously ...

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA: Basel Wednesday, November 26, 2025, 09:00 Hrs ...

Although deep learning–based image recognition technology is rapidly advancing, it still remains difficult to clearly explain the criteria AI uses ...

Vision shapes behavior and, a new study by MIT neuroscientists finds, behavior and internal states shape vision.

New research shows that the prefrontal cortex doesn’t simply broadcast generic commands to sensory regions—it sends finely tailored signals that shape how the brain processes vision depending on ...

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...